Indaptus Therapeutics (INDP) Payables (2020 - 2026)
Indaptus Therapeutics (INDP) reported Payables of $615,426 for Q2 2026, down 92.7% from $8.48 million a year earlier and down 34.0% from the prior quarter.
Powered by 
Analysis
Indaptus Therapeutics (INDP) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Indaptus Therapeutics posted Payables of $6.16 million, up 86.1% from FY2024.
- Payables has a five-year compound annual growth rate of 59.4% (FY2020 to FY2025).
- By year, Payables came in at $3.31 million in FY2024 (+23.9%), $2.67 million in FY2023 (-20.3%), $3.35 million in FY2022 (-25.6%) and $4.51 million in FY2021 (+653.3%).
- The Q2 2026 figure ranks as the lowest quarterly Payables since Q2 2021.
- Year over year, Payables gained in five of the last eight quarters, with growth averaging 49.4%.
- The high point for year-over-year Payables in five years was Q2 2022 (growth of 788.2%); the low point was Q2 2026 (a decline of 92.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $932,999 (Q1 2026), $6.16 million (Q4 2025) and $2.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Indaptus Therapeutics | 210.93 Mn | 183.54 Mn | - | 615,426.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 615,426.00 |
| Mar 31, 2026 | 932,999.00 |
| Dec 31, 2025 | 6.16 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 8.48 Mn |
| Mar 31, 2025 | 2.55 Mn |
| Dec 31, 2024 | 3.31 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 2.67 Mn |
| Sep 30, 2023 | 2.26 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.72 Mn |
| Dec 31, 2022 | 3.35 Mn |
| Sep 30, 2022 | 2.78 Mn |
| Jun 30, 2022 | 3.53 Mn |
| Mar 31, 2022 | 3.58 Mn |
| Dec 31, 2021 | 4.51 Mn |
| Sep 30, 2021 | 5.78 Mn |
API Access
Indaptus Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=INDP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "INDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=INDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();